Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Study of the underlying event in top quark pair production in <math></math> collisions at 13 <math></math>.

The European physical journal. C, Particles and fields·2019

Same author

Measurement of charged particle spectra in minimum-bias events from proton-proton collisions at <math> </math>.

The European physical journal. C, Particles and fields·2019

Same author

Measurement of the weak mixing angle using the forward-backward asymmetry of Drell-Yan events in <math></math> collisions at 8 <math></math>.

The European physical journal. C, Particles and fields·2019

Same author

Search for third-generation scalar leptoquarks decaying to a top quark and a <math></math> lepton at <math> </math>.

The European physical journal. C, Particles and fields·2019

Same author

Search for single production of vector-like quarks decaying to a top quark and a <math></math> boson in proton-proton collisions at <math> </math>.

The European physical journal. C, Particles and fields·2019

Same author

[Meta-analysis of the influence of prophylactic central lymph node dissection on the prognosis of patients with thyroid micropapillary carcinoma].

Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery·2019

Search research articles

Related Experiment Video

Updated: Jun 1, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Utilizing ¹⁸F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Demonstrating Intertumoural Differences in Vascular-Metabolic Phenotype with Dynamic Contrast-Enhanced CT-PET.

K A Miles¹, R E Williams, D Yu

¹Brighton and Sussex Medical School, University of Sussex, Brighton BN1 9RH, UK.

International Journal of Molecular Imaging

|June 2, 2011

Summary

Dynamic contrast-enhanced CT (DCE-CT) and FDG-PET imaging reveal distinct vascular-metabolic relationships in lymphoma masses versus colorectal liver metastases. Lymphoma masses show higher perfusion, differentiating them from liver metastases.

More Related Videos

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT)

Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT)

Published on: May 2, 2012

Related Experiment Videos

Last Updated: Jun 1, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Utilizing ¹⁸F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT)

Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT)

Published on: May 2, 2012

Area of Science:

Oncology
Radiology
Medical Imaging

Background:

Histopathological studies suggest differing vascular-metabolic profiles between lymphoma and colorectal liver metastases.
Previous research indicates potential differences in tumor microenvironment and cellular activity.

Purpose of the Study:

To evaluate if combined dynamic contrast-enhanced CT (DCE-CT) and fluorodeoxyglucose positron emission tomography (FDG-PET) can demonstrate vascular-metabolic differences between lymphoma and colorectal liver metastases.
To compare tumor perfusion and glucose metabolism in these distinct malignant entities.

Main Methods:

Retrospective analysis of DCE-CT and FDG-PET scans from patients with lymphoma masses (n=11) or colorectal liver metastases (CRM, n=12).
Tumor vascularity quantified using DCE-CT perfusion measurements.
Tumor glucose metabolism assessed by mean FDG Standardised Uptake Value (SUV(FDG)).
Vascular-metabolic relationships analyzed via SUV(FDG)/perfusion ratios and Pearson correlation.

Main Results:

Active lymphoma (AL) demonstrated significantly higher tumor perfusion (0.65 mL/min/mL) compared to CRM (0.37 mL/min/mL) (P = .031), despite similar SUV(FDG) values.
AL also showed higher perfusion than inactive lymphoma (IL) (0.24 mL/min/mL) (P = .006).
The SUV(FDG)/perfusion ratio was significantly higher in CRM (15.3 min) than IL (4.2 min) (P < .01).
No significant correlation between SUV(FDG) and perfusion was observed across patient groups.

Conclusions:

Combined DCE-CT and FDG-PET imaging can differentiate lymphoma masses from colorectal liver metastases based on their vascular-metabolic relationships.
Lymphoma masses, particularly active ones, exhibit higher tumor perfusion compared to colorectal liver metastases.
These imaging findings support distinct tumor microenvironment characteristics between lymphoma and colorectal liver metastases.